Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Pharma
Roche's juggernaut Vabysmo routs analyst consensus
In the first quarter, Roche's Vabysmo racked up sales of 847M Swiss francs, which was up 108% and demolished analysts' consensus.
Kevin Dunleavy
Apr 24, 2024 11:29am
Orphan drug market to reach $270B by 2028: Evaluate
Apr 24, 2024 12:01am
Roche's Alecensa snags FDA postsurgery nod in lung cancer
Apr 19, 2024 11:03am
Roche touts near-complete MS suppression for injectable Ocrevus
Apr 17, 2024 11:00am
Roche eyes earlier treatment nod after Columvi-chemo trial win
Apr 15, 2024 11:36am
Top 20 pharma companies by 2023 revenue
Apr 15, 2024 3:00am